|
Press Releases and Ad-hoc-Announcements 2005
December 21, 2005
|
| Regulatory authority’s notification shortens
preparation period for dSLIM clinical studies
 more
|
December 12, 2005
|
| MOLOGEN AG was granted European patent MIDGE-TH1
more
|
November 11, 2005
|
| MOLOGEN: MIDGE-TH1 patent will be granted in Europe
more
|
November 10, 2005
|
| MOLOGEN submits report on third quarter: The course
is set on a positive future
more
|
October 12, 2005
|
| MOLOGEN AG raises funds for clinical trials by
increasing share capital
more
|
September 30, 2005
|
| MOLOGEN AG strengthened liquidity by successful
capital increase
more
|
September 22, 2005
|
| MOLOGEN receives manufacturing authorisation for
a DNA vaccine
more
|
August 11, 2005
|
| MOLOGEN strengthens basis for positive business
development with non-recurring expenditure. Positive prognosis for the
remaining year
Ad-hoc-Mitteilung more
Press Releases more
 Half-year Report 2005 
download
|
July 21, 2005
|
| MOLOGEN AG adapts executive board structure to
future growth. Company expands board to three members, appoints new chief
financial officer
more
|
|
|
NEWSLETTER |
| To subscribe to our Newsletter please
 click here
|
|
|
PRESS
RELEASES 
